Últimos ensayos

EudraCT Number: 2004-002408-13 Sponsor Protocol Number: C LF 178P 0401 Start Date: 2005-02-10
Sponsor Name: FOURNIER Laboratories Ireland Ltd
Full Title: A randomised, double-blind study comparing the efficacy and safety of 145mg NanoCrystal® fenofibrate, 10mg ezetimibe and their combination in patients with type IIb dyslipidemia and features of the...
Medical condition: Patients with type IIb dyslipidemia and features of the metabolic syndrome.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) BE (Completed)
Trial results: View results
EudraCT Number: 2004-005108-33 Sponsor Protocol Number: Short2-INF-RIBA Start Date: 2005-02-10
Sponsor Name: AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
Full Title: RANDOMISED CONTROLLED STUDY ON EARLY RENSPONSE TO COMBINED ANTIVIRAL THERAPY IN CHRONIC H EPATITIS C PATIENTS GENOTIPE 2 AND 3 WITH HCV-RNA NEGATIVE WEEK 4
Medical condition: SOSTAINED BIOCHEMICAL AND VIROLOGICAL RESPONSE TO COMBINADET THERAPY PEGILATED RIBAVIRIN IN CHRONIC HEPATITIES PATIENTS G 2 AND 3
Disease: Version SOC Term Classification Code Term Level
9.1 10019663 Hepatic failure LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Ongoing)
Trial results: (No results available)
EudraCT Number: 2004-005112-83 Sponsor Protocol Number: Short1/4-INF-RIBA Start Date: 2005-02-10
Sponsor Name: AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
Full Title: RANDOMISED CONTROLLED STUDY ON EARLY RESPONSE TO COMBINED ANTIVIRAL THERAPY IN CHRONIC EPATITES C PATIENT GENOTIPE 1 AND 4 WITH HCV RNA NEGATIVE WEEK 6
Medical condition: SOSTAINED BIOCHEMICAL AND VIROLOGICAL RESPONSE TO COMBINATED THERAPY PEGILATED RIBAVIRIN IN CHRONIC EPATITIES PATIENTS G 1 AND 4
Disease: Version SOC Term Classification Code Term Level
6.1 10019663 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Ongoing)
Trial results: (No results available)
EudraCT Number: 2004-004278-10 Sponsor Protocol Number: 2004/R/AN/04 Start Date: 2005-02-10
Sponsor Name: Lothian Health Board- University Hospitals Division [...] 1. Lothian Health Board- University Hospitals Division 2. Lothian Health Board University Hospitals Division
Full Title: Determination of the subarachnoid ED50 and ED95 of hyperbaric 0.5% bupivacaine when co-administered with diamorphine hydrochloride for caesarean section
Medical condition: patients undergoing elective caesarean section
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2004-000806-39 Sponsor Protocol Number: CECOG/BREAST.2.2.005 Start Date: 2005-02-10
Sponsor Name: CECOG
Full Title: Randomized Phase II Study of Dose-Dense Fluorouracil Plus Epirubicin75 Plus Cyclophosphamide (FEC75) and Fluorouracil Plus Epirubicin90 Plus Cyclophosphamide (FEC90) as Adjuvant Therapy for Early B...
Medical condition: Early Breast Cancer
Disease: Version SOC Term Classification Code Term Level
7.0 10006199 PT
Population Age: Adults Gender: Female
Trial protocol: HU (Completed) SK (Completed)
Trial results: (No results available)
EudraCT Number: 2004-000023-15 Sponsor Protocol Number: H7T-MC-TAAL Start Date: 2005-02-10
Sponsor Name: Eli Lilly and Company Limited
Full Title: A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects who are to Undergo Percutaneous Coronary Intervention
Medical condition: Reduction of atherothrombotic events in patients with acute coronary syndromes (ACS) that is patients with ST-segment elevation MI [STEMI], non-ST-segment elevation MI [NSTEMI], or unstable angina...
Disease: Version SOC Term Classification Code Term Level
7.0 10011085 HLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Completed) AT (Completed) FI (Completed) HU (Completed) CZ (Completed) SK (Completed) DE (Completed) IT (Completed) LT (Completed) EE (Completed) LV (Completed) IS (Completed) ES (Completed) DK (Completed)
Trial results: View results
EudraCT Number: 2004-000655-41 Sponsor Protocol Number: CFTY720A2308 Start Date: 2005-02-10
Sponsor Name: Novartis Farmacéutica S.A
Full Title: A one-year, multicenter, open-label, feasibility study to evaluate the safety and the efficacy of FTY720 5mg introduction and CNI elimination in adult maintenance renal transplant reicpients mainta...
Medical condition: prevention of acute rejection in maintenance renal transplant recipients
Disease: Version SOC Term Classification Code Term Level
7.0 10023439 LLT
Population Age: Adults Gender: Male, Female
Trial protocol: ES (Completed)
Trial results: View results
EudraCT Number: 2004-004727-36 Sponsor Protocol Number: NR 8230-3/2004 Start Date: 2005-02-10
Sponsor Name: Charles University, 3rd Faculty of Medicine
Full Title: Influence of low-dose i.v. growth hormone treatment together with glutamine supplementation in late-phase critically ill patient after multiple injury. A pilot study.
Medical condition: Prolonged phase of critical illness after severe multiple trauma
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Female
Trial protocol: CZ (Ongoing)
Trial results: (No results available)
EudraCT Number: 2004-003820-37 Sponsor Protocol Number: IGIT-008 Start Date: 2005-02-10
Sponsor Name: Bracco Imaging Spa
Full Title: A multicentre study to evaluate the Contibution of SonoVue® and CnTI technology (Contrast Tuned Imaging) to a correct classification of Adnexal Masses as benign or malignant
Medical condition: COMPLEX ADNEXAL MASS IN PELVIS
Disease: Version SOC Term Classification Code Term Level
10029104 SOC
Population Age: Adults, Elderly Gender: Female
Trial protocol: SE (Completed) IT (Completed)
Trial results: View results
EudraCT Number: 2004-005095-17 Sponsor Protocol Number: EA041999 Start Date: 2005-02-10
Sponsor Name: Engelhard Arzneimittel GmbH & Co. KG
Full Title: Randomised, double-blind, placebo-controlled, monocentric phase III study on the efficacy and safety of Lidocaine 8 mg Sore Throat Lozenges in patients with moderate to severe acute sore throat not...
Medical condition: The study will be performed in patients suffering from acute sore throat not necessarily to be treated with antibiotics
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: (No results available)

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir